Solena heterophylla

Names and Synonyms

Scientific Names

Accepted name

Synonyms

• Zehneria heterophylla
• Melothria marginata var. heterophylla
• Melothria heterophylla

Sources: Wikidata, Catalogue of Life

Taxonomical Classification

This plant, known scientifically as Solena heterophyllia, belongs to the kingdom Plantae and the phylum Streptophyta. Within the class Equisetopsida and subclass Magnoliidae, it is categorized under the order Cucurbitales and the family Cucurbitaceae. It is specifically classified under the genus Solena.

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

This plant exhibits a broad geographical distribution across several key regions of Asia. In Western Asia, its presence is specifically noted within the borders of Afghanistan. Its range extends significantly into China, where it can be found in the South-Central and Southeast regions. Additionally, the species inhabits the high-altitude areas of Tibet. Finally, its distribution reaches into Eastern Asia, specifically occurring on the island of Taiwan.

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Ecology

The ecology of Solena heterophyllas is characterized by its specific niche within montane ecosystems, where it occupies an elevational range that typically reaches a mean of 800 m AMSL. This species thrives in particular microclimates defined by these altitudinal parameters, which influence the moisture availability, temperature fluctuations, and light penetration essential for its survival. The distribution of the plant is closely tied to the environmental gradients found at these mid-to-high elevations, where the soil composition and atmospheric conditions support its specialized physiological requirements. By maintaining its presence within this specific vertical stratum of the landscape, Solena heterophyllas plays a distinct role in the biological interactions and nutrient cycling processes unique to its habitat.

Elevational range mean:

800 m AMSL

Life history

The life history of Solena heterophyllas is characterized by an annual lifecycle, meaning the plant completes its entire developmental process—from germination to seed production—within a single growing season. In terms of its ecological strategy and structural growth, it is classified as a therophyte, a life form defined by its reliance on highly resistant seeds to survive unfavorable environmental conditions during dormant periods. This strategy ensures that the plant can rapidly exploit seasonal resources before returning to a seed state, effectively navigating its habitat through this specialized survival mechanism.

Life form :

therophyte

Lifecycle :

annual

Morphology

The morphology of Solena heterophylla is characterized by its growth form as a non-woody herb that functions as an obligatory climber, relying on external structures for support as it ascends. As an independent organism, it does not exhibit parasitic behavior and maintains a terrestrial lifestyle rather than growing as an epiphyte. Its structural composition is entirely non-woody, consistent with its classification as a herbaceous plant.

Climber :

obligatory

Epiphyte :

terrestrial

Growth form :

herb

Parasite :

independent

Woodiness :

non-woody

Sources: Global Inventory of Floras and Traits (GIFT)

Chemicals

Solena heterophylla has 1 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include Cucurbitacin B.

Cucurbitacin B

1. Endocrine, metabolic & immune disorders drug targets

Activities

Solena heterophylla has 1 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include Analgesic.

Analgesic

1. Medicines (Basel, Switzerland)

Conditions

Solena heterophylla has 1 reported investigations on conditions identified across 0 scientific publications and several other databases. The most consistently reported conditions include oxidative stress.

Oxidative stress

1. Endocrine, metabolic & immune disorders drug targets